Additional information
White Powder
1105067-93-3
ACI-011219
99.5-101.5°C
C33H33FN2O4
540.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl]-5-hydroxyhept-2-enoic acid sodium salt
(S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl]-5-hydroxyhept-2-enoic acid sodium salt
(2E)-2,3-Dehydroxy Atorvastatin





![6,9-DIACYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,9-diyl (2R,2'R,3S,3'S)-bis(3-benzamido-2-hydroxy-3-phenylpropanoate))](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)